Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for Silo Pharma (SILO) over the last 3 years, with Q4 2023 value amounting to $5891.0.

  • Silo Pharma's Accumulated Expenses fell 9589.78% to $5891.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $5891.0, marking a year-over-year decrease of 9589.78%. This contributed to the annual value of $5891.0 for FY2023, which is 9589.78% down from last year.
  • Per Silo Pharma's latest filing, its Accumulated Expenses stood at $5891.0 for Q4 2023, which was down 9589.78% from $20134.0 recorded in Q1 2023.
  • Over the past 5 years, Silo Pharma's Accumulated Expenses peaked at $143607.0 during Q4 2022, and registered a low of $5891.0 during Q4 2023.